FBR & Co’s Pfizer PFE Stock Holding History

FBR & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-42,160	Closed	-$1.12M	–	52
2013 Q2	$1.12M	Buy	+42,160	New	+$1.16M	1.43%	20

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

FBR & Co's PFE Position: Q3 2013 in Review

FBR & Co sold out of Pfizer (PFE) in Q3 2013, closing a stake of 42,160 shares — an estimated $1.12M sold.

FBR & Co first reported a position in PFE in Q2 2013 and held it in 1 quarter. The position peaked at $1.12M in Q2 2013. 1,606 funds tracked by Wall St. Rank hold PFE as of Q3 2013.

FBR & Co reported no remaining Pfizer position as of Q3 2013 after selling out during the quarter.
FBR & Co sold 42,160 Pfizer shares in Q3 2013, an estimated $1.12M.
FBR & Co first reported a position in Pfizer in Q2 2013 and held it in 1 quarter.
FBR & Co's Pfizer position peaked at $1.12M in Q2 2013.
1,606 funds tracked by Wall St. Rank held Pfizer as of Q3 2013.

Based on FBR & Co's 13F filing for Q3 2013, filed 7 Nov 2013.